1 |
Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
DOI
|
2 |
Brownstein, M., Russell, J. and Gainer, H. 1980. Synthesis, transport, and release of posterior pituitary hormones. Science 207, 373-378.
DOI
|
3 |
Burbach, J., Luckman, S., Murphy, D. and Gainer, H. 2001. Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiol. Rev. 81, 1197-1267.
DOI
|
4 |
Caldwell, H. K., Lee, H. J., Macbeth, A. H. and Young, W. S. 2008. Vasopressin: behavioral roles of an "original" neuropeptide. Prog. Neurobiol. 84, 1-24.
DOI
|
5 |
Caldwell, H. K. and Young, W. S. 2006. Oxytocin and Vasopressin: Genetics and Behavioral Implications, pp. 573-607. In: Lim, R. (ed.), Neuroactive Proteins and Peptides. Springer: New York, USA.
|
6 |
Chang, T. H., Huang, H. Y., Hsu, J. B. K., Weng, S. L., Horng, J. T. and Huang, H. D. 2013. An enhanced computational platform for investigating the roles of regulatory RNA and for identifying functional RNA motifs. BMC Bioinformatics 14, S4.
|
7 |
Choi, J. W., Kang, S. M., Lee, Y., Hong, S. H., Sanek, N. A., Young, W. S. and Lee, H. J. 2013. MicroRNA profiling in the mouse hypothalamus reveals oxytocin-regulating microRNA. J. Neurochem. 126, 331-337.
DOI
|
8 |
Kim, Y. K., Heo, I. and Kim, V. N. 2010. Modifications of small RNAs and their associated proteins. Cell 143, 703- 709.
DOI
|
9 |
Lee, H. J. 2014. Additional stories of microRNAs. Exp. Biol. Med. 239, 1275-1279.
DOI
|
10 |
Lee, H. J. 2013. Exceptional stories of microRNAs. Exp. Biol. Med. 238, 339-343.
DOI
|
11 |
Lee, H. J., Macbeth, A. H., Pagani, J. H. and Young, W. S. 2009. Oxytocin: the great facilitator of life. Prog. Neurobiol. 88, 127-151.
DOI
|
12 |
Lewis, B. P., Burge, C. B. and Bartel, D. P. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
DOI
|
13 |
Qin, W., Shi, Y., Zhao, B., Yao, C., Jin, L., Ma, J. and Jin, Y. 2010. miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS One 5, e9429.
DOI
|
14 |
Stoop, R. 2012. Neuromodulation by Oxytocin and Vasopressin.Neuron 76, 142-159.
DOI
|
15 |
Young, W. S. and Gainer, H. 2003. Transgenesis and the study of expression, cellular targeting and function of oxytocin, vasopressin and their receptors. Neuroendocrinology 78, 185-203.
DOI
|